Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia

Acquired haemophilia is a rare disorder requiring therapy to control bleeding and to suppress the inhibitory antibody. High-dose intravenous immunoglobulin is commonly used as part of immunosuppressive regimens for this condition. We describe the case of an elderly patient who developed acute oligur...

Full description

Saved in:

Bibliographic Details
Published in:	Haemophilia : the official journal of the World Federation of Hemophilia Vol. 5; no. 2; pp. 124 - 126
Main Authors:	McColl, M D, Omran, A, Walker, I D, Lowe, G D
Format:	Journal Article
Language:	English
Published:	England 01-03-1999
Subjects:	Acute Kidney Injury - etiology Aged Aged, 80 and over Dose-Response Relationship, Immunologic Hemophilia A - complications Hemophilia A - therapy Humans Immunoglobulins, Intravenous - adverse effects Immunoglobulins, Intravenous - therapeutic use Male
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Acquired haemophilia is a rare disorder requiring therapy to control bleeding and to suppress the inhibitory antibody. High-dose intravenous immunoglobulin is commonly used as part of immunosuppressive regimens for this condition. We describe the case of an elderly patient who developed acute oliguric renal failure as a result of intravenous immunoglobulin therapy. All patients receiving such treatment should have renal function carefully monitored both during and after the infusion.
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	1351-8216 1365-2516
DOI:	10.1046/j.1365-2516.1999.00292.x